SAM
JBIO

Sectoral Asset Management’s Jade Biosciences JBIO Stock Holding History

Sectoral Asset Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,601
Closed -$3.06M – 110
2022
Q2 		$3.06M Sell
5,601
-654
-10% -$312K 0.62% 64
2022
Q1 		$4.01M Sell
6,255
-1,824
-23% -$708K 0.71% 55
2021
Q4 		$3.33M Sell
8,079
-1,674
-17% -$847K 0.5% 70
2021
Q3 		$7.16M Sell
9,753
-4,533
-32% -$2.54M 0.6% 68
2021
Q2 		$11.4M Buy
+14,286
New +$11.4M 0.92% 44

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sectoral Asset Management's JBIO Position: Q3 2022 in Review

Sectoral Asset Management sold out of Jade Biosciences (JBIO) in Q3 2022, closing a stake of 5,601 shares — an estimated $3.06M sold.

Sectoral Asset Management first reported a position in JBIO in Q2 2021 and held it in 5 quarters. The position peaked at $11.4M in Q2 2021. 55 funds tracked by Wall St. Rank hold JBIO as of Q3 2022.

  • Sectoral Asset Management reported no remaining Jade Biosciences position as of Q3 2022 after selling out during the quarter.
  • Sectoral Asset Management sold 5,601 Jade Biosciences shares in Q3 2022, an estimated $3.06M.
  • Sectoral Asset Management first reported a position in Jade Biosciences in Q2 2021 and held it in 5 quarters.
  • Sectoral Asset Management's Jade Biosciences position peaked at $11.4M in Q2 2021.
  • 55 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2022.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.